# Administration of GnRH Antagonist to Oocyte Donation Recipients

> **NCT00635258** · — · COMPLETED · sponsor: **Centro Ginecologia y Obstetricia.** · enrollment: 100 (actual)

## Conditions studied

- Pregnancy
- Embryo Implantation

## Interventions

- **DRUG:** triptorelin (Decapeptyl®, Ipsen Pharma, Barcelona, Spain)
- **DRUG:** GnRH antagonist (Orgalutran®)

## Key facts

- **NCT ID:** NCT00635258
- **Lead sponsor:** Centro Ginecologia y Obstetricia.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2008-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00635258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00635258, "Administration of GnRH Antagonist to Oocyte Donation Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00635258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*